Home » BIOSYSTEMS INTERNATIONAL LICENCES NORTHEASTERN UNIVERSITY TECHNOLOGY FOR BIOMARKER DISCOVERY
BIOSYSTEMS INTERNATIONAL LICENCES NORTHEASTERN UNIVERSITY TECHNOLOGY FOR BIOMARKER DISCOVERY
BioSystems International and Northeastern University (Boston MA) announce that
they have signed a Licence Agreement for The University's "Monoclonal antibody
based biomarker discovery and development platform." BioSystems International
(BSI) discovers and validates biomarkers through partnerships with pharmaceutical,
biotechnology and diagnostics companies and in-house research programs or academic
collaborations.
International
News Service
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May